<sup>90</sup>Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases.

Wang, Jing; Baidoun, Firas; Tun, Han W; Alhaj Moustafa, Muhamad

⁹⁰Yttrium Ibritumomab Tiuxetan (Zevalin) for the Treatment of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Report of 5 Cases.

Wang, Jing; Baidoun, Firas; Tun, Han W; Alhaj Moustafa, Muhamad.

Afiliação

Wang J; Department of Internal Medicine, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Baidoun F; Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Tun HW; Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.
Alhaj Moustafa M; Division of Hematology and Medical Oncology, Mayo Clinic Florida, Jacksonville, FL, 32224, USA.

Blood Lymphat Cancer ; 13: 59-65, 2023.

Article em En | MEDLINE | ID: mdl-37810176

Palavras-chave

CD20; Zevalin; chronic lymphocytic leukemia; radioimmunotherapy; small lymphocytic lymphoma; targeted irradiation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Lymphat Cancer Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Blood Lymphat Cancer Ano de publicação: 2023 Tipo de documento: Article